Navigation Links
New Zeus Biomimetic Coated PICC Now Available
Date:8/26/2009

r4 Vascular announces the commercial availability of the new Zeus™ Coated CT Peripherally-inserted Central Catheter (PICC). A novel coating on the catheter surface mimics the glycocalyx layer found on natural endothelial tissue surfaces in vessel walls. Laboratory tests prove that mimicking the glycocalyx layer can dramatically reduce thrombus formation on the internal and external surface of the catheter.

Maple Grove, MN (Vocus) August 26, 2009 -- r4 Vascular announces the commercial availability of the new Zeus™ Coated CT Peripherally-inserted Central Catheter (PICC). A novel coating on the catheter surface mimics the glycocalyx layer found on natural endothelial tissue surfaces in vessel walls. Laboratory tests prove that mimicking the glycocalyx layer can dramatically reduce thrombus formation on the internal and external surface of the catheter.

According to Gail Sansivero, MS, ANP, Vascular and Interventional Radiology Nurse Practitioner, Albany Medical Center, "Thrombus can be a real problem for patients with PICCs. Biologically, a patient responds to a catheter insertion within 24 hours by developing bio-film, leading to thrombus that can cause catheter occlusion, infection, or dislodge into the bloodstream."

Developing the catheter, r4 Vascular engineers took a cue from stealth coating technologies, approaching the thrombus problem by camouflaging the catheter in a biomimetic coating. Laboratory testing has shown the coating to be so effective that the Zeus™ Coated CT Catheter is the first non-valved PICC to receive FDA clearance for saline-only maintenance.

The Zeus™ Coated CT PICC is one of several keynote technologically-advanced catheter systems from r4 Vascular. r4 Vascular marks its entry into the vascular access marketplace with the Zeus™ Coated CT PICC, and the Pegasus™ Uncoated CT PICC. The two catheters will debut at the 23rd Annual Scientific Meeting of the Association for Vascular Access, being held September 15-17, 2009 in Las Vegas, NV. A new drainage catheter designed for easier placement and exchange is also now available from r4 Vascular.

According to r4 Vascular President, Donald Geer, "r4 Vascular's commitment is to save hospitals money and improve patient care, consequently we launched the Zeus Coated CT PICC to reduce thrombus complications and their related expenses; but we also recognize that not all patients will be exposed to the complications that our biomimetic coating was designed to reduce, so we launched our uncoated Pegasus PICC for patients that may not require a coated catheter."

r4 Vascular is a privately-held vascular access company driving innovation in vascular access medical technology. r4's passion is "uncomplicating" venous access, chemotherapy, and drug delivery, through product improvements that help catheters remain patent and effective, with reduced risk of complications.

# # #

Read the full story at http://www.prweb.com/releases/biomimetic_coating/coated_PICC/prweb2792954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. DNA-coated nanotubes help kill tumors without harm to surrounding tissue
2. New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA
3. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
4. Newest Coated Stent Does Well in Real-World Trial
5. Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
6. Drug-Coated Stents Better at Keeping Arteries Open
7. Drug-Coated Sponges May Limit Catheter Infections
8. UT Southwestern researchers find drug-coated stents less risky for heart bypass patients
9. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
10. Coated Stents Better Than Bare Metal Ones in Short Run
11. Coated Stents Best for Heart Patients With Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Zeus Biomimetic Coated PICC Now Available
(Date:1/15/2017)... ... January 15, 2017 , ... ... is a program that strives to better communities around the world by offering ... It also provides the opportunity for team members to become involved in a ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine recently ... Area counties for 2017. Almost 1,000 nominations were submitted and a little over ... Results were announced the magazine’s January 2017 issue . , Under the ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy ... expanding line of activated charcoal products. With more and more people opting to ... products according to how they cater to specific needs. , Moody Zook focused ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... ... that raise blood sugar levels. Counting carbohydrates is as easy as checking the ... only nutrient that affects blood sugar levels. Despite being sugar-free, proteins can influence ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... ... Moody Zook has taken on the challenge of providing additional organic alternatives for ... During the launch of the brand’s new line of all-natural activated charcoal products, ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... 16, 2017 Transparency Market Research states ... Devices Market  held a huge share of 43% in 2015. ... frontrunners in the overall market, grabbing the undivided attention of ... across geographies, and strong product portfolio is expected to keep ... ...
(Date:1/16/2017)... , Jan. 16, 2017  Dovetail Genomics today announced ... and assembly service, which yields chromosome-scale genome assemblies. The ... a Dovetail-hosted workshop on Jan. 17 at the Plant ... San Diego . "We are thrilled ... launch of our Dovetail Hi-C offering," said Todd ...
(Date:1/16/2017)... 2017  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased ... , CFA to its Board of Directors. He is ... Asset Management LLC . He is also the Chief ... investment advisory firm with over $1.5 billion under management. ... in security analysis and portfolio management. He began his ...
Breaking Medicine Technology: